Corinne H. Nevinny is Director at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 8 open-market trades across 4 companies since 2010, most recently 2023-05-23.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PODD | SELL | 2021-05-13 | 2021-05-14 | $231.42 | $432K | +14.4% | +23.4% | +22.3% |
| PODD | SELL | 2020-04-30 | 2020-05-04 | $196.21 | $651K | +3.3% | -7.3% | +3.7% |
| NBIX | SELL | 2018-05-07 | 2018-05-09 | $83.13 | $416K | +5.3% | +14.1% | +34.8% |
| NBIX | SELL | 2017-05-05 | 2017-05-08 | $53.98 | $270K | +3.4% | -13.9% | +3.8% |
| NBIX | SELL | 2016-08-08 | 2016-08-09 | $48.54 | $243K | -0.3% | +3.6% | -9.4% |
| ONXX | SELL · 10b5-1 | 2013-07-30 | 2013-07-31 | $131.26 | $197K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-07-01 | 2013-07-02 | $132.63 | $663K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2013-06-19 | 2013-06-21 | $88.25 | $88K | N/A | N/A | N/A |
| ONXX | SELL | 2012-11-28 | 2012-12-03 | $75.00 | $297K | N/A | N/A | N/A |
| EW | SELL | 2010-05-10 | 2010-05-11 | $100.46 | $603K | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2010-02-11 | 2010-02-16 | $85.44 | $854K | -4.2% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.